OrmoSys is a German EU Horizon2020-funded high-technology company for innovative orthopedic insoles which are designed on a sophisticated, scalable and dynamic real-time analysis of human gait.
Our vision is to improve people’s quality of life and health every day with our break-through orthopedic solution.
OrmoSys combines a dynamic and holistic analysis method with an efficient and modularized manufacturing process. That creates a customized and innovative product.
Founder and CEO
Fatmir Langmeier is a passionate developer, innovator and visionary pioneer in the orthopedics market. With over 20 years of professional experience, he sets standards in the industry as an innovation leader.
Career highlights and honours:
Year: Economist BDA-certificate
2007: Winner of the Innovation Award
2008: Winner of the Leonardo Award
Since year: Board member of the Bavarian Federation for Orthopedic Shoe Technology
EU Horizon 2020
Horizon 2020 is the largest EU research and innovation initiative of the European Union. With almost €80 billion of funding available over 7 years (2014 to 2020), break-through innovations are promoted from the initial idea to commercialization.
EIT Health is a network of best-in-class health innovators backed by the EU. Solutions to enable European citizens to live longer, healthier lives are supported by promoting innovation at the intersection of research, education and business.
German Federal Ministry of Economic Affairs and Technology (BMWi)
The essential task of the German BMWi is to shape the conditions that foster successful economic activity on the basis of personal and entrepreneurial freedom, competition and stability. The BMWi pursues the objective to create a pro-innovation policy environment.
OrmoSys is active in the key markets Europe and the United States
Rosenheimer Str. 42
+49 (0) 8035 873 92 32
60313 Frankfurt am Main
+49 (0) 069 2108 7656